210 results on '"Krackhardt, Florian"'
Search Results
2. The effect of gender on clinical outcomes following routine revascularizations with polymer-free sirolimus-eluting stents
3. Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial
4. Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
5. Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
6. Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter?
7. Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial
8. Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
9. Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study
10. Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
11. The effect of gender on clinical outcomes following routine revascularizations with polymer-free sirolimus-eluting stents
12. Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
13. Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry
14. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
15. Clinical outcomes following polymer-free sirolimus-eluting stent implantations in unselected patients: A descriptive subgroup analysis in patients with renal impairment
16. Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice
17. Porcine arteriogenesis based on vasa vasorum in a novel semi-acute occlusion model using high-resolution imaging
18. Insights into coronary collateral formation from a novel porcine semiacute infarction model
19. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports
20. Valve embolization during transcatheter aortic valve implantation: Incidence, risk factors and follow-up by computed tomography
21. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
22. Results from the “Me & My Heart” (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome
23. Propensity score‐based analysis of 30‐day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices
24. N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy
25. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial
26. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial
27. Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter?
28. Patient with heart failure: importance to treat valvular diseases
29. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
30. High‐risk Patients
31. A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
32. Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial
33. Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes
34. Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description
35. Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
36. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy
37. Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study
38. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
39. Design and rationale for the “Me & My Heart” (eMocial) study: A randomized evaluation of a new smartphone‐based support tool to increase therapy adherence of patients with acute coronary syndrome
40. Delayed coronary obstruction after lotus transcatheter aortic valve replacement treated with left main stent in stent implantation
41. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
42. Mode-of-action of the PROPELLA concept in fulminant myocarditis
43. Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
44. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries
45. Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry
46. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
47. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
48. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
49. FP550NINE-MONTH CLINICAL OUTCOMES IN DIALYSIS PATIENTS FOLLOWING POLYMER-FREE SIROLIMUS-ELUTING STENT IMPLANTATIONS
50. Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.